Therapeutic Decision-Making and Outcomes in Elderly Patients With Severe Symptomatic Aortic Stenosis: Prognostic Implications of Elderly Patients' Initial Decisions

Qinghao Zhao, Haiyan Xu, Qingrong Liu, Yunqing Ye, Bin Zhang, Zhe Li, Runlin Gao, Yongjian Wu, Qinghao Zhao, Haiyan Xu, Qingrong Liu, Yunqing Ye, Bin Zhang, Zhe Li, Runlin Gao, Yongjian Wu

Abstract

Background: Despite clear indications for intervention, therapeutic decision-making for elderly patients with severe symptomatic aortic stenosis (AS) remains a complex issue due to the wide variation in individual risk profiles and the involvement of patients' subjective preferences. We aimed to investigate the reasons leading to the decisions against intervention and the consequences thereof on survival. Methods: Data were derived from the China Elderly Valve Disease (China-DVD) Cohort Study on patients aged ≥60-year-old with severe symptomatic AS consecutively enrolled between September to December 2016. Patients were analyzed according to the initial therapeutic decisions made by consensus between patients and physicians at the time of the index evaluation: intervention group (patients who were evaluated as suitable for intervention and accepted the treatment proposal); patient-refusal group (patients who were evaluated as suitable for intervention but refused due to subjective preferences); physician-deny group (patients who were denied intervention by physicians after evaluation). The least absolute shrinkage and selection operator (LASSO)-penalized logistic regression model was used to identify the factors associated with physicians' decisions against intervention. Twelve-month survival was analyzed using Cox proportional hazards models, with multivariate adjustment using inverse probability weighting (IPW). Results: Among the enrolled 456 elderly patients with severe symptomatic AS, 52 (11.4%) patients refused intervention and 49 (10.7%) patients were denied intervention by their physicians. LASSO-penalized logistic regression model identified that reduced left ventricular ejection fraction and increased EuroSCORE-II were strongly associated with physicians' decisions against intervention. At 12-month follow-up, only 8 (15.4%) patients who initially refused the intervention proposal underwent the subsequent intervention, with an average delay of 195 days. Patients' initial decisions against intervention were significantly associated with 12-month mortality, even after IPW adjustment (Hazard ratio: 2.61; 95% confidence interval: 1.09-6.20; P = 0.031). Conclusions: The decision against intervention was taken in about one-fifth of elderly patients with symptomatic severe AS, half of which were due to patients' subjective preferences. Surgical risk remains the primary concern for physicians when making therapeutic decisions. Elderly patients' initial decisions against intervention have a profound impact on subsequent intervention rates and prognosis, and therefore should be treated as a "risk factor" at the subjective level. Clinical Trial Registration: clinicaltrials.gov/ct2/show/NCT02865798, China elDerly Valve Disease (China-DVD) cohort study (NCT02865798).

Keywords: aortic stenosis; aortic valve replacement; elderly; outcomes; therapeutic decision making.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2021 Zhao, Xu, Liu, Ye, Zhang, Li, Gao and Wu.

Figures

Figure 1
Figure 1
Study cohort flow diagram.
Figure 2
Figure 2
Analysis of the factors associated with physicians' decisions against intervention using LASSO-penalized logistic regression model. (A) The plot showing the deviance values of the LASSO model as a function of the tuning parameter λ. The optimal λ is the value that minimizes the deviance curve (dashed line). (B) Trace plot showing non-zero model coefficients as a function of the tuning parameter λ. As the λ increases, LASSO sets various coefficients to zero, thus removing them from the model. When λ corresponds to the minimum-deviance (dashed line), two variables are selected (C).
Figure 3
Figure 3
Analysis of the predictors of 12-month mortality using LASSO-penalized Cox regression model. (A) The plot showing the deviance values of the LASSO model as a function of the tuning parameter λ. The optimal λ is the value that minimizes the deviance curve (dashed line). (B) Trace plot showing non-zero model coefficients as a function of the tuning parameter λ. As the λ increases, LASSO sets various coefficients to zero, thus removing them from the model. When λ corresponds to the minimum-deviance (dashed line), five variables are selected (C).
Figure 4
Figure 4
Kaplan-Meier survival curves for patients with different therapeutic decisions. The plot showing the survival distributions of patients who accepted the intervention proposal (Blue); refused the intervention proposal (Yellow); were denied intervention by physicians (Red), as well as the expected survival of the age- and sex-specific general population (Green). The dash lines represent the crude survival rates and the solid lines indicate the adjusted survival rates using IPW.

References

    1. Iung B, Delgado V, Rosenhek R, Price S, Prendergast B, Wendler O, De Bonis M, Tribouilloy C, Evangelista A, Bogachev-Prokophiev A, et al. . Contemporary presentation and management of valvular heart disease: the EUrobservational research programme valvular heart disease II survey. Circulation. (2019) 140:1–38. 10.1161/CIRCULATIONAHA.119.041080
    1. Lindman BR, Clavel M-A, Mathieu P, Iung B, Lancellotti P, Otto CM, Pibarot P. Calcific aortic stenosis. Nat Rev Dis Prim. (2016) 2:1–28. 10.1038/nrdp.2016.6
    1. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Muñoz DR, et al. . 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. (2017) 38:2739–86. 10.1016/j.rec.2017.12.013
    1. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O'Gara PT. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. (2017) 70:252–89. 10.1016/j.jacc.2017.03.011
    1. Langanay T, Flécher E, Fouquet O, Ruggieri VG, Tour BD La, Félix C, Lelong B, Verhoye JP, Corbineau H, Leguerrier A. Aortic valve replacement in the elderly: the real life. Ann Thorac Surg. (2012) 93:70–8. 10.1016/j.athoracsur.2011.07.033
    1. Bouma BJ, Brink Van Den RBA, Meulen Van Der JHP, Verheul HA, Cheriex EC. To operate or not on elderly patients with aortic stenosis : the decision and its consequences. Heart. (1999) 82:143–8. 10.1136/hrt.82.2.143
    1. Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, Gohlke-Bärwolf C, Boersma E, Ravaud P, Vahanian A. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. (2005) 26:2714–20. 10.1093/eurheartj/ehi471
    1. Piérard S, Seldrum S, De Meester C, Pasquet A, Gerber B, Vancraeynest D, El Khoury G, Noirhomme P, Robert A, Vanoverschelde JL. Incidence, determinants, and prognostic impact of operative refusal or denial in octogenarians with severe aortic stenosis. Ann Thorac Surg. (2011) 91:1107–12. 10.1016/j.athoracsur.2010.12.052
    1. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, et al. . 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol. (2014) 63:57–185. 10.1161/CIR.0000000000000029
    1. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Clin Epidemiol. (1987) 40:373–83. 10.1016/0021-9681(87)90171-8
    1. Nashef SAM, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, Lockowandt U. Euroscore ii. Eur J cardio-thoracic Surg. (2012) 41:734–45. 10.1093/ejcts/ezs043
    1. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, et al. . Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging. (2015) 16:233–71. 10.1093/ehjci/jev014
    1. Hastie T, Tibshirani R, Tibshirani R. Best Subset, Forward Stepwise or Lasso? Analysis and Recommendations Based on Extensive Comparisons. Stat Sci. (2020) 35:579–92. 10.1214/19-STS733
    1. National Bureau of Statistics of China . China Population and Employment Statistics Yearbook. China Statistics Press; (2016).
    1. Haukoos JS, Lewis RJ. The propensity score. JAMA. (2015) 314:1637–8. 10.1001/jama.2015.13480
    1. Tjang YS, van Hees Y, Körfer R, Grobbee DE, van der Heijden GJMG. Predictors of mortality after aortic valve replacement. Eur J Cardio-thoracic Surg. (2007) 32:469–74. 10.1016/j.ejcts.2007.06.012
    1. Edwards FH, Peterson ED, Coombs LP, DeLong ER, Jamieson WRE, Shroyer ALW, Grover FL. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol. (2001) 37:885–92. 10.1016/S0735-1097(00)01202-X
    1. Ad N, Holmes SD, Patel J, Pritchard G, Shuman DJ, Halpin L. Comparison of EuroSCORE II, Original EuroSCORE, and The Society of Thoracic Surgeons Risk Score in Cardiac Surgery Patients. Ann Thorac Surg. (2016) 102:573–9. 10.1016/j.athoracsur.2016.01.105
    1. Bouma BJ, van den Brink RB, Zwinderman K, Cheriex EC, Hamer HH, Lie KI, Tijssen JG. Which elderly patients with severe aortic stenosis benefit from surgical treatment? An aid to clinical decision making. J Heart Valve Dis. (2004) 13:374–81.
    1. Roques F, Nashef SAM, Michel P, Gauducheau E, De Vincentiis C, Baudet E, Cortina J, David M, Faichney A, Gavrielle F. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardio-thoracic Surg. (1999) 15:816–23. 10.1016/S1010-7940(99)00106-2
    1. Florath I, Rosendahl UP, Mortasawi A, Bauer SF, Dalladaku F, Ennker IC, Ennker JC. Current determinants of operative mortality in 1400 patients requiring aortic valve replacement. Ann Thorac Surg. (2003) 76:75–83. 10.1016/S0003-4975(03)00341-2
    1. Kvidal P, Bergström R, Hörte LG, Stahle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol. (2000) 35:747–56. 10.1016/S0735-1097(99)00584-7
    1. Charlson E, Legedza ATR, Hamel MB. Decision-making and outcomes in severe symptomatic aortic stenosis. J Heart Valve Dis. (2006) 15:312–321.
    1. Rothman MD, Van Ness PH, O'Leary JR, Fried TR. Refusal of medical and surgical interventions by older persons with advanced chronic disease. J Gen Intern Med. (2007) 22:982–7. 10.1007/s11606-007-0222-4
    1. Divo MJ, Martinez CH, Mannino DM. Ageing and the epidemiology of multimorbidity. Eur Respir J. (2014) 44:1055–68. 10.1183/09031936.00059814
    1. van Riet EES, Hoes AW, Wagenaar KP, Limburg A, Landman MAJ, Rutten FH. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail. (2016) 18:242–52. 10.1002/ejhf.483
    1. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KKL, Murabito JM, Vasan RS. Long-Term Trends in the Incidence of and Survival with Heart Failure. N Engl J Med. (2002) 347:1397–402. 10.1056/NEJMoa020265
    1. Van Mieghem NM, Dumonteil N, Chieffo A, Roux Y, Van Der Boon RMA, Giustino G, Hartman E, Aga Y, De Jong L, Ghanem MA, et al. . Current decision making and short-term outcome in patients with degenerative aortic stenosis: the pooled-Rotterdam-Milano-Toulouse in collaboration aortic stenosis survey. EuroIntervention. (2016) 11:e1305–13. 10.4244/EIJV11I10A253
    1. Alkhouli M, Alqahtani F, Ziada KM, Aljohani S, Holmes DR, Mathew V. Contemporary trends in themanagement of aortic stenosis in the USA. Eur Heart J. (2020) 41:921–8. 10.1093/eurheartj/ehz568
    1. Hon JKF, Tay E. Transcatheter aortic valve implantation in Asia. Ann Cardiothorac Surg. (2017) 6:504. 10.21037/acs.2017.08.05

Source: PubMed

3
S'abonner